{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:59:04Z","timestamp":1793372344702,"version":"4.5.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T00:00:00Z","timestamp":1567555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.vaccine.2019.08.086","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T17:22:16Z","timestamp":1568136136000},"page":"A132-A140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"special_numbering":"S1","title":["Global oral cholera vaccine use, 2013\u20132018"],"prefix":"10.1016","volume":"38","author":[{"given":"Lorenzo","family":"Pezzoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.08.086_b0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1128\/microbiolspec.PoH-0012-2015","article-title":"Cholera","volume":"4","author":"Lippi","year":"2016","journal-title":"Microbiol Spectr"},{"issue":"38","key":"10.1016\/j.vaccine.2019.08.086_b0010","first-page":"489","article-title":"Cholera, 2017","volume":"93","author":"World Health Organization","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"issue":"6","key":"10.1016\/j.vaccine.2019.08.086_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003832","article-title":"Updated global burden of cholera in endemic countries","volume":"9","author":"Ali","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.08.086_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(17)30559-7","article-title":"Cholera","author":"Clemens","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2019.08.086_b0025","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.publhealth.18.1.283","article-title":"The public health aspects of complex emergencies and refugee situations","volume":"18","author":"Toole","year":"1997","journal-title":"Annu Rev Public Health"},{"issue":"3","key":"10.1016\/j.vaccine.2019.08.086_b0030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.trstmh.2007.10.015","article-title":"Use of Lot Quality Assurance Sampling (LQAS) to estimate vaccination coverage helps guide future vaccination efforts","volume":"102","author":"Alberti","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2019.08.086_b0035","first-page":"134","article-title":"Epidemic cholera in Latin America, 1991\u20131993: implications of case definitions used for public health surveillance","volume":"30","author":"Koo","year":"1996","journal-title":"Bull Pan Am Health Organ"},{"issue":"24","key":"10.1016\/j.vaccine.2019.08.086_b0040","first-page":"305","article-title":"New momentum in prevention, control and elimination of cholera in Africa: priority actions identified by affected countries","volume":"91","author":"World Health Organization","year":"2016","journal-title":"Wkly Epidemiol Rec"},{"issue":"34","key":"10.1016\/j.vaccine.2019.08.086_b0045","first-page":"477","article-title":"Cholera vaccines: WHO position paper - August 2017","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"issue":"4","key":"10.1016\/j.vaccine.2019.08.086_b0050","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/S2214-109X(16)00037-1","article-title":"A second affordable oral cholera vaccine: implications for the global vaccine stockpile","volume":"4","author":"Desai","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"3","key":"10.1016\/j.vaccine.2019.08.086_b0055","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/21645515.2016.1245250","article-title":"Achievements and challenges for the use of killed oral cholera vaccines in the global stockpile era","volume":"13","author":"Desai","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.08.086_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(17)30359-6","article-title":"Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis","author":"Bi","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2019.08.086_b0065","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S1473-3099(13)70273-1","article-title":"5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial","volume":"13","author":"Bhattacharya","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2019.08.086_b0070","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1473-3099(14)70999-5","article-title":"The development of global vaccine stockpiles","volume":"15","author":"Yen","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2019.08.086_b0075","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1080\/21645515.2015.1096457","article-title":"Vaccine-preventable diseases in humanitarian emergencies among refugee and internally-displaced populations","volume":"11","author":"Lam","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.08.086_b0080","doi-asserted-by":"crossref","first-page":"203","DOI":"10.11604\/pamj.2016.23.203.8346","article-title":"Feasibility and acceptability of oral cholera vaccine mass vaccination campaign in response to an outbreak and floods in Malawi","volume":"23","author":"Msyamboza","year":"2016","journal-title":"Pan Afr Med J"},{"issue":"1","key":"10.1016\/j.vaccine.2019.08.086_b0085","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3201\/eid2301.160881","article-title":"Oral cholera vaccine coverage during an outbreak and humanitarian crisis, Iraq, 2015","volume":"23","author":"Lam","year":"2017","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.08.086_b0090","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1473-3099(15)00298-4","article-title":"The scenario approach for countries considering the addition of oral cholera vaccination in cholera preparedness and control plans","volume":"16","author":"Deen","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.08.086_b0095","first-page":"231","article-title":"When, how, and where can oral cholera vaccines be used to interrupt cholera outbreaks?","volume":"379","author":"Clemens","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.08.086_b0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.vaccine.2013.11.066","article-title":"Twenty-five years of the WHO vaccines prequalification programme (1987\u20132012): lessons learned and future perspectives","volume":"33","author":"Dellepiane","year":"2015","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2019.08.086_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001901","article-title":"The first use of the global oral cholera vaccine emergency stockpile: lessons from south Sudan","volume":"12","author":"Abubakar","year":"2015","journal-title":"PLoS Med"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.08.086_b0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12919-016-0068-z","article-title":"The African cholera surveillance network (Africhol) consortium meeting, 10\u201311 June 2015, Lome, Togo","volume":"11","author":"Munier","year":"2017","journal-title":"BMC Proc"},{"issue":"6","key":"10.1016\/j.vaccine.2019.08.086_b0115","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2471\/BLT.17.207175","article-title":"Oral cholera vaccine in cholera prevention and control, Malawi","volume":"96","author":"M'bangombe","year":"2018","journal-title":"Bull World Health Organ"},{"issue":"32","key":"10.1016\/j.vaccine.2019.08.086_b0120","first-page":"437","article-title":"Deployments from the oral cholera vaccine stockpile, 2013\u20132017","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"issue":"12","key":"10.1016\/j.vaccine.2019.08.086_b0125","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2471\/BLT.14.139949","article-title":"Post-licensure deployment of oral cholera vaccines: a systematic review","volume":"92","author":"Martin","year":"2014","journal-title":"Bull World Health Organ"},{"issue":"38","key":"10.1016\/j.vaccine.2019.08.086_b0130","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1016\/j.vaccine.2017.07.104","article-title":"Oral cholera vaccine coverage in hard-to-reach fishermen communities after two mass Campaigns, Malawi, 2016","volume":"35","author":"Sauvageot","year":"2017","journal-title":"Vaccine"},{"issue":"44","key":"10.1016\/j.vaccine.2019.08.086_b0135","doi-asserted-by":"crossref","first-page":"6491","DOI":"10.1016\/j.vaccine.2017.10.108","article-title":"Innovative vaccine delivery strategies in response to a cholera outbreak in the challenging context of Lake Chilwa. A rapid qualitative assessment","volume":"36","author":"Heyerdahl","year":"2018","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/j.vaccine.2019.08.086_b0140","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1016\/j.vaccine.2019.05.044","article-title":"Effectiveness of oral cholera vaccine in preventing cholera among fishermen in Lake Chilwa, Malawi: a case-control study","volume":"37","author":"Grandesso","year":"2019","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2019.08.086_b0145","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.1016\/S2214-109X(16)30211-X","article-title":"Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study","volume":"4","author":"Azman","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"33","key":"10.1016\/j.vaccine.2019.08.086_b0150","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1016\/j.vaccine.2016.05.038","article-title":"Perceptions of oral cholera vaccine and reasons for full, partial and non-acceptance during a humanitarian crisis in South Sudan","volume":"34","author":"Peprah","year":"2016","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2019.08.086_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005652","article-title":"Neighborhood-targeted and case-triggered use of a single dose of oral cholera vaccine in an urban setting: feasibility and vaccine coverage","volume":"11","author":"Parker","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"20","key":"10.1016\/j.vaccine.2019.08.086_b0160","first-page":"214","article-title":"Oral cholera vaccine campaign among internally displaced persons in South Sudan","volume":"89","author":"World Health Organization","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"issue":"5","key":"10.1016\/j.vaccine.2019.08.086_b0165","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1473-3099(16)30523-0","article-title":"Safety of a killed oral cholera vaccine (Shanchol) in pregnant women in Malawi: an observational cohort study","volume":"17","author":"Ali","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"4_Suppl","key":"10.1016\/j.vaccine.2019.08.086_b0170","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4269\/ajtmh.16-1023","article-title":"Cost evaluation of a government-conducted oral cholera vaccination campaign-Haiti, 2013","volume":"97","author":"Routh","year":"2017","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2019.08.086_b0175","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2471\/BLT.16.189241","article-title":"Implementation research: reactive mass vaccination with single-dose oral cholera vaccine, Zambia","volume":"96","author":"Poncin","year":"2018","journal-title":"Bull World Health Organ"},{"issue":"36","key":"10.1016\/j.vaccine.2019.08.086_b0180","first-page":"521","article-title":"Cholera, 2016","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"issue":"6","key":"10.1016\/j.vaccine.2019.08.086_b0185","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.vaccine.2006.09.049","article-title":"Safety and immunogenicity of a reformulated Vietnamese bivalent killed, whole-cell, oral cholera vaccine in adults","volume":"25","author":"Anh","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2019.08.086_b0190","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4269\/ajtmh.14-0683","article-title":"A randomized, placebo-controlled trial evaluating safety and immunogenicity of the killed, bivalent, whole-cell oral cholera vaccine in Ethiopia","volume":"93","author":"Desai","year":"2015","journal-title":"Am J Trop Med Hyg"},{"issue":"10001","key":"10.1016\/j.vaccine.2019.08.086_b0195","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0140-6736(15)61140-0","article-title":"Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial","volume":"386","author":"Qadri","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2019.08.086_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099381","article-title":"Safety and immunogenicity of a live oral recombinant cholera vaccine VA1. 4: a randomized, placebo controlled trial in healthy adults in a cholera endemic area in Kolkata, India","volume":"9","author":"Kanungo","year":"2014","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2019.08.086_b0205","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3346\/jkms.2014.29.4.494","article-title":"Safety and immunogenicity assessment of an oral cholera vaccine through phase I clinical trial in Korea","volume":"29","author":"Baik","year":"2014","journal-title":"J Korean Med Sci"},{"issue":"9702","key":"10.1016\/j.vaccine.2019.08.086_b0210","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/S0140-6736(09)61297-6","article-title":"Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial","volume":"374","author":"Sur","year":"2009","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.vaccine.2019.08.086_b0215","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa1312680","article-title":"Use of Vibrio cholerae vaccine in an outbreak in Guinea","volume":"370","author":"Luquero","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2019.08.086_b0220","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa043323","article-title":"Effectiveness of mass oral cholera vaccination in Beira, Mozambique","volume":"352","author":"Lucas","year":"2005","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2019.08.086_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001512","article-title":"Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea","volume":"10","author":"Ciglenecki","year":"2013","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.vaccine.2019.08.086_b0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001006","article-title":"Use of oral cholera vaccines in an outbreak in Vietnam: a case control study","volume":"5","author":"Anh","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2019.08.086_b0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002465","article-title":"First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012","volume":"7","author":"Luquero","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2019.08.086_b0240","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/trstmh\/tru153","article-title":"Feasibility of a preventive mass vaccination campaign with two doses of oral cholera vaccine during a humanitarian emergency in South Sudan","volume":"108","author":"Porta","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.vaccine.2019.08.086_b0245","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3201\/eid2106.141797","article-title":"Oral cholera vaccine coverage, barriers to vaccination, and adverse events following vaccination, Haiti, 2013","volume":"21","author":"Tohme","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2019.08.086_b0250","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.vaccine.2015.10.112","article-title":"Mass vaccination with a two-dose oral cholera vaccine in a long-standing refugee camp, Thailand","volume":"34","author":"Phares","year":"2016","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2019.08.086_b0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005210","article-title":"Use of oral cholera vaccine and knowledge, attitudes, and practices regarding safe water, sanitation and hygiene in a long-standing refugee camp, Thailand, 2012\u20132014","volume":"10","author":"Scobie","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2019.08.086_b0260","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1473-3099(17)30055-5","article-title":"Cholera vaccination: pregnant women excluded no more","volume":"17","author":"Moro","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2019.08.086_b0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004274","article-title":"Pregnancy outcomes after a mass vaccination campaign with an oral cholera vaccine in Guinea: a retrospective cohort study","volume":"9","author":"Grout","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2019.08.086_b0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001743","article-title":"Safety of the recombinant cholera toxin B subunit, killed whole-cell (rBS-WC) oral cholera vaccine in pregnancy","volume":"6","author":"Hashim","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2019.08.086_b0275","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.vaccine.2017.01.080","article-title":"Safety of the oral cholera vaccine in pregnancy: retrospective findings from a subgroup following mass vaccination campaign in Dhaka, Bangladesh","volume":"35","author":"Khan","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.08.086_b0280","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12889-016-2710-0","article-title":"Sociocultural determinants of anticipated oral cholera vaccine acceptance in three African settings: a meta-analytic approach","volume":"16","author":"Sundaram","year":"2016","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2019.08.086_b0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002629","article-title":"Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model","volume":"8","author":"Kar","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2019.08.086_b0290","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2471\/BLT.16.175166","article-title":"Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings","volume":"95","author":"Hsiao","year":"2017","journal-title":"Bull World Health Organ"},{"issue":"12","key":"10.1016\/j.vaccine.2019.08.086_b0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005124","article-title":"Oral cholera vaccination delivery cost in low- and middle-income countries: an analysis based on systematic review","volume":"10","author":"Mogasale","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2019.08.086_b0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004072","article-title":"An estimation of private household costs to receive free oral cholera vaccine in Odisha, India","volume":"9","author":"Mogasale","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"38","key":"10.1016\/j.vaccine.2019.08.086_b0305","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.1016\/j.vaccine.2015.07.042","article-title":"Estimating the cost of cholera-vaccine delivery from the societal point of view: a case of introduction of cholera vaccine in Bangladesh","volume":"33","author":"Sarker","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2019.08.086_b0310","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.4269\/ajtmh.14-0159","article-title":"Evaluation of targeted mass cholera vaccination strategies in Bangladesh: a demonstration of a new cost-effectiveness calculator","volume":"91","author":"Troeger","year":"2014","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"10.1016\/j.vaccine.2019.08.086_b0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001844","article-title":"Costs of illness due to cholera, costs of immunization and cost-effectiveness of an oral cholera mass vaccination campaign in Zanzibar","volume":"6","author":"Schaetti","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2019.08.086_b0320","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jama.279.7.521","article-title":"Treatment and vaccination strategies to control cholera in sub-Saharan refugee settings: a cost-effectiveness analysis","volume":"279","author":"Naficy","year":"1998","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.vaccine.2019.08.086_b0325","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4269\/ajtmh.13-0183","article-title":"Use of oral cholera vaccine in Haiti: a rural demonstration project","volume":"89","author":"Ivers","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"13","key":"10.1016\/j.vaccine.2019.08.086_b0330","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.vaccine.2016.02.020","article-title":"The oral cholera vaccine Shanchol when stored at elevated temperatures maintains the safety and immunogenicity profile in Bangladeshi participants","volume":"34","author":"Saha","year":"2016","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2019.08.086_b0335","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/14760584.2017.1249470","article-title":"Improving immunization approaches to cholera","volume":"16","author":"Saha","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"17","key":"10.1016\/j.vaccine.2019.08.086_b0340","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.vaccine.2016.10.091","article-title":"Extending supply chains and improving immunization coverage and equity through controlled temperature chain use of vaccines","volume":"35","author":"Kahn","year":"2017","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2019.08.086_b0345","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.vaccine.2014.01.038","article-title":"Benefits of using vaccines out of the cold chain: delivering meningitis A vaccine in a controlled temperature chain during the mass immunization campaign in Benin","volume":"32","author":"Zipursky","year":"2014","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2019.08.086_b0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022971","article-title":"The role of vaccine coverage within social networks in cholera vaccine efficacy","volume":"6","author":"Root","year":"2011","journal-title":"PLoS ONE"},{"issue":"9479","key":"10.1016\/j.vaccine.2019.08.086_b0355","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0140-6736(05)66550-6","article-title":"Herd immunity conferred by killed oral cholera vaccines in Bangladesh: a reanalysis","volume":"366","author":"Ali","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2019.08.086_b0360","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/INF.0b013e318149dffd","article-title":"Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission","volume":"27","author":"Ali","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2019.08.086_b0365","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1093\/ije\/dyl100","article-title":"Relationship between neighbourhood-level killed oral cholera vaccine coverage and protective efficacy: evidence for herd immunity","volume":"35","author":"Emch","year":"2006","journal-title":"Int J Epidemiol"},{"issue":"11","key":"10.1016\/j.vaccine.2019.08.086_b0370","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1473-3099(12)70196-2","article-title":"Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study","volume":"12","author":"Khatib","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2019.08.086_b0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002120","article-title":"Potential for controlling cholera using a ring vaccination strategy: re-analysis of data from a cluster-randomized clinical trial","volume":"13","author":"Ali","year":"2016","journal-title":"PLoS Med"},{"issue":"11","key":"10.1016\/j.vaccine.2019.08.086_b0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001901","article-title":"Urban cholera transmission hotspots and their implications for reactive vaccination: evidence from Bissau city, Guinea bissau","volume":"6","author":"Azman","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2019.08.086_b0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001867","article-title":"The impact of a one-dose versus two-dose oral cholera vaccine regimen in outbreak settings: a modeling study","volume":"12","author":"Azman","year":"2015","journal-title":"PLoS Med"},{"issue":"4","key":"10.1016\/j.vaccine.2019.08.086_b0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005482","article-title":"Controlling cholera in the Ouest Department of Haiti using oral vaccines","volume":"11","author":"Kirpich","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2019.08.086_b0395","doi-asserted-by":"crossref","first-page":"7081","DOI":"10.1073\/pnas.1102149108","article-title":"Vaccination strategies for epidemic cholera in Haiti with implications for the developing world","volume":"108","author":"Chao","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.vaccine.2019.08.086_b0400","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3201\/eid2206.151592","article-title":"Population-level effect of cholera vaccine on displaced populations, south Sudan, 2014","volume":"22","author":"Azman","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2019.08.086_b0405","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cit009","article-title":"Herd protection by a bivalent killed whole-cell oral cholera vaccine in the slums of Kolkata","volume":"56","author":"Ali","year":"2013","journal-title":"India. Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2019.08.086_b0410","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.4269\/ajtmh.15-0700","article-title":"Effectiveness of oral cholera vaccine in Haiti: 37-month follow-up","volume":"94","author":"Severe","year":"2016","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2019.08.086_b0415","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S1473-3099(17)30184-6","article-title":"Vaccination against cholera in Juba - Authors' reply","volume":"17","author":"Ciglenecki","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2019.08.086_b0420","doi-asserted-by":"crossref","first-page":"e162","DOI":"10.1016\/S2214-109X(14)70368-7","article-title":"Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis","volume":"3","author":"Ivers","year":"2015","journal-title":"Lancet Glob Health"},{"issue":"4","key":"10.1016\/j.vaccine.2019.08.086_b0425","doi-asserted-by":"crossref","first-page":"671","DOI":"10.4269\/ajtmh.13-0171","article-title":"Cholera vaccination in urban Haiti","volume":"89","author":"Rouzier","year":"2013","journal-title":"Am J Trop Med Hyg"},{"issue":"9831","key":"10.1016\/j.vaccine.2019.08.086_b0430","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(12)60832-0","article-title":"Oral cholera vaccine and integrated cholera control in Haiti","volume":"379","author":"Ivers","year":"2012","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2019.08.086_b0435","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/trstmh\/tru077","article-title":"Cholera in Africa: new momentum in fighting an old problem","volume":"108","author":"Mengel","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19311855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19311855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:38:29Z","timestamp":1759401509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19311855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":87,"alternative-id":["S0264410X19311855"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.086","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global oral cholera vaccine use, 2013\u20132018","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}